|
|
Incorporated in 1999, Gujarat based Par Drugs and Chemicals Limited is engaged in the business of manufacturing and developing active pharma ingredients (API) for the Indian and international markets. APIs are used as the main ingredient in making tablets, capsules, and other finished dosages. The company also produces various antacid molecules.
It has two manufacturing facilities located at Ankleshwar and Bhavnagar in Gujarat. Currently, the company has a total of 6 Fine Chemical and 12 API products which are available in the market of 17 countries, including India. Some of the customers of the company are Dabur India Ltd, Meyer Organics Pvt. Ltd, Cadila Healthcare Ltd., Cipla Ltd, and Pfizer Ltd. For fiscal 2018, the international and domestic operations recorded 86.88% and 13.12%, respectively from the total company sales.
The company has a testing laboratory to maintain quality standards for finished products and raw materials. Par Drugs and Chemicals Ltd also performs drying operations of the products provided by customers in the liquid form and converts them into powders.
The competitive strengths of the company are:
1. Diversified product range
2. International presence
3. Prompt sales & distribution network
4. A good track record
5. Strong chemistry capabilities
Falgun Vallabhbhai Savani and Jignesh Vallabhbhai Savani are the promoters of the company.
| Particulars | For the year/period ended (in Rs. Lakhs) | ||||
|---|---|---|---|---|---|
| 31-Mar-19 | 31-Mar-18 | 31-Mar-17 | 31-Mar-16 | ||
| Total Assets | 5,135.55 | 5,393.89 | 5,604.14 | 5,803.08 | |
| Total Revenue | 4,641.20 | 4,241.65 | 4,880.90 | 3,326.43 | |
| Profit After Tax | 241.88 | 149.53 | 184.78 | 42.18 | |
The Net Proceeds from Issue towards the following objects:
1. Funding the working capital requirements of the Company; and
2. General corporate purposes.
| IPO Opening Date | May 3, 2019 |
| IPO Closing Date | May 8, 2019 |
| Issue Type | Fixed Price Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹51 per equity share |
| Market Lot | 2000 Shares |
| Min Order Quantity | 2000 Shares |
| Listing At | NSE SME |
| Issue Size | 1,672,000 Eq Shares of ₹10 (aggregating up to ₹8.53 Cr) |
| Fresh Issue | 1,672,000 Eq Shares of ₹10 (aggregating up to ₹[.] Cr) |
The Par Drugs IPO open date is May 3, 2019, and the close date is May 8, 2019. The issue may list on May 16, 2019.
| IPO Open Date | May 3, 2019 |
| IPO Close Date | May 8, 2019 |
| Basis of Allotment Date | May 13, 2019 |
| Initiation of Refunds | May 14, 2019 |
| Credit of Shares to Demat Account | May 15, 2019 |
| IPO Listing Date | May 16, 2019 |
The Par Drugs IPO market lot size is 2000 shares. A retail-individual investor can apply for up to 1 lots (2000 shares or ₹102,000).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 2000 | ₹102,000 |
| Maximum | 1 | 2000 | ₹102,000 |
| Pre Issue Share Holding | 99.55% |
| Post Issue Share Holding | 72.82 |
Investors may consider investment for the long term. Based on financial parameters (including P/BV data) issue appears reasonably priced. Promoters have converted shares at Rs. 66 while the issue is priced lower. Employees too are offered shares at the same price of IPO. Read detail review...
The Par Drugs IPO is subscribed 5.74 times on 5/8/2019 5:00:00 PM. The public issue subscribed 7.97 times in the retail category, times in the QIB category, and 3.48 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| NII | 3.48 |
| Retail | 7.97 |
| Employee | 1.00 |
| Total | 5.74 |
| Listing Date | Thursday, May 16, 2019 |
| BSE Script Code | |
| NSE Symbol | PAR |
| Listing In | |
| ISIN | INE04LG01015 |
| IPO Price | ₹51 per equity share |
| Face Value | ₹10 per equity share |
|
|
Par Drugs and Chemicals Limited
805, Dwarkesh Complex,
R.C. Dutt Road,
Alkapuri, Vadodara-390 007,
Phone: +91 265 2332018
Email: cs.sanket@pardrugs.com
Website: http://pardrugs.com/
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: pardrugs.ipo@linkintime.co.in
Website: https://linkintime.co.in/
Par Drugs IPO is a SME IPO of 1,672,000 equity shares of the face value of ₹10 aggregating up to ₹8.53 Crores. The issue is priced at ₹51 per equity share. The minimum order quantity is 2000 Shares.
The IPO opens on May 3, 2019, and closes on May 8, 2019.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
The Par Drugs IPO opens on May 3, 2019 and closes on May 8, 2019.
Par Drugs IPO lot size is 2000 Shares and the minimum order quantity is 2000 Shares.
You can apply in Par Drugs IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Par Drugs IPO will be done on May 13, 2019, and the allotted shares will be credited to your demat account by May 15, 2019. Check the Par Drugs IPO allotment status.
Useful Articles
IPO Guru (1400+ Posts, 3100+ Likes)
IPO Mentor (700+ Posts, 200+ Likes)
Top Contributor (400+ Posts, 200+ Likes)
